RNU7-155P

Across TCGA pan-cancer cohorts, RNU7-155P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU7-155P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU7-155P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-155P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

HNSC, SKCM, and ESCA are the cancer types where RNU7-155P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.261	0.663	.003	81	view →
SKCM	OS	Tertile	All	0.233	0.787	.004	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
OV	DFS	Tertile	III,IV	0.848	0.150	.020	36	view →
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →
BRCA	OS	Tertile	All	0.159	0.579	.028	24	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU7-155P–HNSC (OS)

Open the HNSC breakdown →